Annual CFI
-$69.14 M
-$159.78 M-176.28%
31 December 2023
Summary:
Assembly Biosciences annual cash flow from investing activities is currently -$69.14 million, with the most recent change of -$159.78 million (-176.28%) on 31 December 2023. During the last 3 years, it has fallen by -$137.21 million (-201.57%). ASMB annual CFI is now -176.28% below its all-time high of $90.64 million, reached on 31 December 2022.ASMB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$24.49 M
+$19.38 M+379.50%
30 September 2024
Summary:
Assembly Biosciences quarterly cash flow from investing activities is currently $24.49 million, with the most recent change of +$19.38 million (+379.50%) on 30 September 2024. Over the past year, it has increased by +$5.61 million (+29.70%). ASMB quarterly CFI is now -68.01% below its all-time high of $76.55 million, reached on 30 June 2020.ASMB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$42.79 M
+$5.61 M+11.59%
30 September 2024
Summary:
Assembly Biosciences TTM cash flow from investing activities is currently -$42.79 million, with the most recent change of +$5.61 million (+11.59%) on 30 September 2024. Over the past year, it has dropped by -$79.86 million (-215.40%). ASMB TTM CFI is now -147.21% below its all-time high of $90.64 million, reached on 31 December 2022.ASMB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASMB Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -176.3% | +29.7% | -215.4% |
| 3 y3 years | -201.6% | +22.0% | -176.8% |
| 5 y5 years | +48.9% | +213.2% | -145.1% |
ASMB Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -176.3% | at low | -25.9% | +127.3% | -147.2% | +38.1% |
| 5 y | 5 years | -176.3% | +48.9% | -68.0% | +125.8% | -147.2% | +38.1% |
| alltime | all time | -176.3% | +48.9% | -68.0% | +125.8% | -147.2% | +68.4% |
Assembly Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $24.49 M(+379.5%) | -$42.79 M(-11.6%) |
| June 2024 | - | $5.11 M(-70.4%) | -$48.39 M(-21.8%) |
| Mar 2024 | - | $17.27 M(-119.3%) | -$61.87 M(-10.5%) |
| Dec 2023 | -$69.14 M(-176.3%) | -$89.65 M(-574.8%) | -$69.14 M(-286.5%) |
| Sept 2023 | - | $18.88 M(-325.7%) | $37.08 M(-25.3%) |
| June 2023 | - | -$8.37 M(-183.7%) | $49.63 M(-26.6%) |
| Mar 2023 | - | $10.00 M(-39.6%) | $67.59 M(-25.4%) |
| Dec 2022 | $90.64 M(+241.8%) | $16.56 M(-47.3%) | $90.64 M(+38.2%) |
| Sept 2022 | - | $31.43 M(+227.5%) | $65.59 M(+21.0%) |
| June 2022 | - | $9.60 M(-71.0%) | $54.23 M(+30.5%) |
| Mar 2022 | - | $33.05 M(-489.5%) | $41.55 M(+56.7%) |
| Dec 2021 | $26.52 M(-61.0%) | -$8.48 M(-142.3%) | $26.52 M(-52.4%) |
| Sept 2021 | - | $20.07 M(-750.1%) | $55.71 M(-491.2%) |
| June 2021 | - | -$3.09 M(-117.1%) | -$14.24 M(-121.8%) |
| Mar 2021 | - | $18.02 M(-13.0%) | $65.39 M(-3.9%) |
| Dec 2020 | $68.07 M(-235.3%) | $20.71 M(-141.5%) | $68.07 M(-242.8%) |
| Sept 2020 | - | -$49.89 M(-165.2%) | -$47.67 M(-574.8%) |
| June 2020 | - | $76.55 M(+269.9%) | $10.04 M(-124.4%) |
| Mar 2020 | - | $20.69 M(-121.8%) | -$41.06 M(-18.4%) |
| Dec 2019 | -$50.32 M(-62.8%) | -$95.02 M(-1315.3%) | -$50.32 M(+188.3%) |
| Sept 2019 | - | $7.82 M(-69.3%) | -$17.45 M(-82.3%) |
| June 2019 | - | $25.45 M(+122.6%) | -$98.87 M(-19.5%) |
| Mar 2019 | - | $11.44 M(-118.4%) | -$122.86 M(-9.3%) |
| Dec 2018 | -$135.40 M(+765.6%) | -$62.16 M(-15.5%) | -$135.40 M(+80.7%) |
| Sept 2018 | - | -$73.60 M(-5134.2%) | -$74.91 M(+2554.6%) |
| June 2018 | - | $1.46 M(-232.9%) | -$2.82 M(-87.9%) |
| Mar 2018 | - | -$1.10 M(-34.3%) | -$23.40 M(+49.6%) |
| Dec 2017 | -$15.64 M(-143.2%) | -$1.67 M(+10.7%) | -$15.64 M(-1021.2%) |
| Sept 2017 | - | -$1.51 M(-92.1%) | $1.70 M(-88.3%) |
| June 2017 | - | -$19.12 M(-387.1%) | $14.53 M(-64.0%) |
| Mar 2017 | - | $6.66 M(-57.5%) | $40.36 M(+11.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $36.20 M(-155.8%) | $15.67 M(+38.4%) | $36.20 M(+116.9%) |
| Sept 2016 | - | $11.32 M(+68.6%) | $16.69 M(-344.9%) |
| June 2016 | - | $6.71 M(+168.8%) | -$6.81 M(-89.1%) |
| Mar 2016 | - | $2.50 M(-165.1%) | -$62.33 M(-3.9%) |
| Dec 2015 | -$64.86 M(<-9900.0%) | -$3.84 M(-68.5%) | -$64.86 M(+5.9%) |
| Sept 2015 | - | -$12.19 M(-75.0%) | -$61.23 M(+26.1%) |
| June 2015 | - | -$48.80 M(>+9900.0%) | -$48.55 M(<-9900.0%) |
| Mar 2015 | - | -$30.70 K(-85.5%) | $249.30 K(-10.1%) |
| Dec 2014 | $277.40 K(-4367.7%) | -$211.40 K(-143.0%) | $277.40 K(-43.1%) |
| Sept 2014 | - | $491.40 K(>+9900.0%) | $487.50 K(<-9900.0%) |
| June 2014 | - | $0.00(-100.0%) | -$3900.00(-57.1%) |
| Mar 2014 | - | -$2600.00(+100.0%) | -$9100.00(+40.0%) |
| Dec 2013 | -$6500.00(+103.1%) | -$1300.00(<-9900.0%) | -$6500.00(+25.0%) |
| Sept 2013 | - | $0.00(-100.0%) | -$5200.00(0.0%) |
| June 2013 | - | -$5200.00(<-9900.0%) | -$5200.00(+62.5%) |
| Mar 2013 | - | $0.00(0.0%) | -$3200.00(0.0%) |
| Dec 2012 | -$3200.00(-73.3%) | $0.00(0.0%) | -$3200.00(0.0%) |
| Sept 2012 | - | $0.00(-100.0%) | -$3200.00(0.0%) |
| June 2012 | - | -$3200.00(<-9900.0%) | -$3200.00(-73.3%) |
| Dec 2011 | -$12.00 K(<-9900.0%) | $0.00(0.0%) | -$12.00 K(0.0%) |
| Sept 2011 | - | $0.00(0.0%) | -$12.00 K(0.0%) |
| June 2011 | - | $0.00(-100.0%) | -$12.00 K(0.0%) |
| Mar 2011 | - | -$12.00 K(<-9900.0%) | -$12.00 K(<-9900.0%) |
| Dec 2010 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2010 | - | $0.00(0.0%) | -$2600.00(0.0%) |
| June 2010 | - | $0.00(0.0%) | -$2600.00(0.0%) |
| Mar 2010 | - | $0.00(-100.0%) | -$2600.00(0.0%) |
| Dec 2009 | -$2600.00(-10.3%) | -$2600.00(<-9900.0%) | -$2600.00(<-9900.0%) |
| Sept 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2009 | - | $0.00 | $0.00 |
| Dec 2008 | -$2900.00 | - | - |
FAQ
- What is Assembly Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Assembly Biosciences?
- What is Assembly Biosciences annual CFI year-on-year change?
- What is Assembly Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Assembly Biosciences?
- What is Assembly Biosciences quarterly CFI year-on-year change?
- What is Assembly Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Assembly Biosciences?
- What is Assembly Biosciences TTM CFI year-on-year change?
What is Assembly Biosciences annual cash flow from investing activities?
The current annual CFI of ASMB is -$69.14 M
What is the all time high annual CFI for Assembly Biosciences?
Assembly Biosciences all-time high annual cash flow from investing activities is $90.64 M
What is Assembly Biosciences annual CFI year-on-year change?
Over the past year, ASMB annual cash flow from investing activities has changed by -$159.78 M (-176.28%)
What is Assembly Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of ASMB is $24.49 M
What is the all time high quarterly CFI for Assembly Biosciences?
Assembly Biosciences all-time high quarterly cash flow from investing activities is $76.55 M
What is Assembly Biosciences quarterly CFI year-on-year change?
Over the past year, ASMB quarterly cash flow from investing activities has changed by +$5.61 M (+29.70%)
What is Assembly Biosciences TTM cash flow from investing activities?
The current TTM CFI of ASMB is -$42.79 M
What is the all time high TTM CFI for Assembly Biosciences?
Assembly Biosciences all-time high TTM cash flow from investing activities is $90.64 M
What is Assembly Biosciences TTM CFI year-on-year change?
Over the past year, ASMB TTM cash flow from investing activities has changed by -$79.86 M (-215.40%)